WO2003052068A3 - Mbcats as modifiers of the beta-catenin pathway and methods of use - Google Patents
Mbcats as modifiers of the beta-catenin pathway and methods of use Download PDFInfo
- Publication number
- WO2003052068A3 WO2003052068A3 PCT/US2002/039796 US0239796W WO03052068A3 WO 2003052068 A3 WO2003052068 A3 WO 2003052068A3 US 0239796 W US0239796 W US 0239796W WO 03052068 A3 WO03052068 A3 WO 03052068A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beta
- methods
- mbcats
- modifiers
- catenin pathway
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002361654A AU2002361654A1 (en) | 2001-12-13 | 2002-12-12 | Mbcats as modifiers of the beta-catenin pathway and methods of use |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34032201P | 2001-12-13 | 2001-12-13 | |
US34031401P | 2001-12-13 | 2001-12-13 | |
US34021301P | 2001-12-13 | 2001-12-13 | |
US60/340,322 | 2001-12-13 | ||
US60/340,213 | 2001-12-13 | ||
US60/340,314 | 2001-12-13 | ||
US35750202P | 2002-02-15 | 2002-02-15 | |
US60/357,502 | 2002-02-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003052068A2 WO2003052068A2 (en) | 2003-06-26 |
WO2003052068A3 true WO2003052068A3 (en) | 2003-10-09 |
Family
ID=27502619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/039796 WO2003052068A2 (en) | 2001-12-13 | 2002-12-12 | Mbcats as modifiers of the beta-catenin pathway and methods of use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002361654A1 (en) |
WO (1) | WO2003052068A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2535897A1 (en) * | 2003-08-14 | 2005-02-24 | Exelixis, Inc. | Sulfs as modifiers of the beta catenin pathway and methods of use |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998600A (en) * | 1997-03-20 | 1999-12-07 | Utrecht University | β-catenin, TCF-4, and APC interact to prevent cancer |
US6303576B1 (en) * | 1999-04-21 | 2001-10-16 | Adherex Technologies Inc. | Compounds and methods for modulating β-catenin mediated gene expression |
-
2002
- 2002-12-12 AU AU2002361654A patent/AU2002361654A1/en not_active Abandoned
- 2002-12-12 WO PCT/US2002/039796 patent/WO2003052068A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998600A (en) * | 1997-03-20 | 1999-12-07 | Utrecht University | β-catenin, TCF-4, and APC interact to prevent cancer |
US6303576B1 (en) * | 1999-04-21 | 2001-10-16 | Adherex Technologies Inc. | Compounds and methods for modulating β-catenin mediated gene expression |
Non-Patent Citations (1)
Title |
---|
PEER BORK: "Powers and pitfalls in sequence analysis: the 70% hurdle", GENOME RESEARCH, vol. 10, 2000, pages 398 - 400, XP002961676 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002361654A1 (en) | 2003-06-30 |
WO2003052068A2 (en) | 2003-06-26 |
AU2002361654A8 (en) | 2003-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002099047A3 (en) | PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
WO2002099074A8 (en) | Slc7s as modifiers of the p53 pathway and methods of use | |
WO2003073823A3 (en) | PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
WO2003014301A3 (en) | Hprp4s as modifiers of the p53 pathway and methods of use | |
WO2003051905A3 (en) | Taojiks as modifiers of the beta-catenin pathway and methods of use | |
WO2002099043A3 (en) | P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
WO2004013309A3 (en) | PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE | |
WO2003035831A3 (en) | Lrrcaps as modifiers of the p53 pathway and methods of use | |
WO2003052068A3 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
WO2004014301A3 (en) | PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE | |
WO2004065542A3 (en) | MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
WO2003074725A3 (en) | MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE | |
WO2004061123A3 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
WO2004048538A3 (en) | Csnks as modifiers of the rac pathway and methods of use | |
WO2004083389A3 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
WO2004048541A3 (en) | Cct6s as modifiers of the rb pathway and methods of use | |
WO2003074671A3 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
WO2004047761A3 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
WO2003074673A3 (en) | Lgals as modifiers of the chk pathway and methods of use | |
WO2003074677A3 (en) | MCHKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE | |
WO2003033656A3 (en) | MSREBPs AS MODIFIERS OF THE SREBP PATHWAY AND METHODS OF USE | |
WO2004083447A3 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
WO2003066811A3 (en) | Msrebps as modifiers of the srebp pathway and methods of use | |
WO2003052070A3 (en) | Vps41s as modifiers of cell death and methods of use | |
WO2003052066A3 (en) | Klcs as modifiers of the p53 pathway and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |